Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Key Points: In AF and cancer patients, rate of bleeding is lower with apixaban, similar in dabigatran and rivaroxaban users, compared to warfarin users. Ischemic stroke rates did not differ among anticoagulant users. Incident VTE risk was lower in all DOAC compared with warfarin users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a663cc · Cited by 1,128 · cited 1×
“This approach has shown to be an effective approach for control of confounding.(24) We stratified by the cancer types as well in our models and the results were similar across the different cancers.”
Result
Research works printed but not linked: 21
- Timp, 2013, Epidemiology of cancer-associated venous thrombosis, Blood, 122, 1712, 10.1182/blood-2013-04-460121 · DOI · Paper page
- Prandoni, 2002, Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis, Blood, 100, 3484, 10.1182/blood-2002-01-0108 · DOI · Paper page
- Lee, 2013, Treatment of cancer-associated thrombosis, Blood, 122, 2310, 10.1182/blood-2013-04-460162 · DOI · Paper page
- Hendrie, 2013, Are new oral anticoagulants ready for use in patients with cancer?, J Natl Compr Canc Netw, 11, 1446, 10.6004/jnccn.2013.0165 · doi:10.6004/jnccn.2013.0165
- Lyman, 2015, Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014, J Clin Oncol, 33, 654, 10.1200/JCO.2014.59.7351 · DOI · Paper page
- Jensen, 2012, A systematic review of validated methods for identifying atrial fibrillation using administrative data, Pharmacoepidemiol Drug Saf, 21, 141, 10.1002/pds.2317 · DOI · Paper page
- Garg, 2011, Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data, Pharmacoepidemiol Drug Saf, 20, 313, 10.1002/pds.2041 · DOI
- Andrade, 2012, A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data, Pharmacoepidemiol Drug Saf, 21, 100, 10.1002/pds.2312 · DOI · Paper page
- Cunningham, 2011, An automated database case definition for serious bleeding related to oral anticoagulant use, Pharmacoepidemiol Drug Saf, 20, 560, 10.1002/pds.2109 · DOI · Paper page
- Wahl, 2010, Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population, Pharmacoepidemiol Drug Saf, 19, 596, 10.1002/pds.1924 · DOI · Paper page
- Cushman, 2004, Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology, Am J Med, 117, 19, 10.1016/j.amjmed.2004.01.018 · DOI · Paper page
- White, 1998, Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California, Ann Intern Med, 128, 737, 10.7326/0003-4819-128-9-199805010-00006 · DOI · Paper page
- Heckbert, 2004, Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women’s Health Initiative, Am J Epidemiol, 160, 1152, 10.1093/aje/kwh314 · DOI · Paper page
- Kniffin, 1994, The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly, Arch Intern Med, 154, 861, 10.1001/archinte.1994.00420080053005 · doi:10.1001/archinte.1994.00420080053005 · Paper page
- Dombkowski, 2009, Asthma surveillance using Medicaid administrative data: a call for a national framework, J Public Health Manag Pract, 15, 485, 10.1097/PHH.0b013e3181a8c334 · doi:10.1097/phh.0b013e3181a8c334
- Rassen, 2011, Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples, Am J Epidemiol, 173, 1404, 10.1093/aje/kwr001 · DOI · Paper page
- Farmakis, 2014, Insights into onco-cardiology: atrial fibrillation in cancer, J Am Coll Cardiol, 63, 945, 10.1016/j.jacc.2013.11.026 · DOI · Paper page
- Khorana, 2007, Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy, J Thromb Haemost, 5, 632, 10.1111/j.1538-7836.2007.02374.x · DOI · Paper page
- Agnelli, 2015, Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial, J Thromb Haemost, 13, 2187, 10.1111/jth.13153 · DOI · Paper page
- Sardar, 2015, New oral anticoagulants in patients with cancer: current state of evidence, Am J Ther, 22, 460, 10.1097/MJT.0000000000000055 · DOI
- Streiff, 2016, Thrombosis in the setting of cancer, Hematology Am Soc Hematol Educ Program, 2016, 196, 10.1182/asheducation-2016.1.196 · DOI
Cited by
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace · doi:10.1093/europace/euab065 · Cited by 1,132
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Herrmann, J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0348-1 · Cited by 747
Metadata
- Authors
- Shah, S., Norby, F. L., Datta, Y. H., Lutsey, P. L., MacLehose, R. F., Chen, L. Y., & Alonso, A.
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2018-01-29
- Volume
- 2
- Issue
- 3
- Pages
- 200-209
- ISSN
- 2473-9529 (ISSN-L)
- 2473-9537
- OpenAlex
- W2787309434
- Cited by
- 173
- References
- 8
- FWCI
- 15.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. https://app.cochat.ai/papers/10.1182/bloodadvances.2017010694
- The paper
- Shah, S., Norby, F. L., Datta, Y. H., Lutsey, P. L., MacLehose, R. F., Chen, L. Y., & Alonso, A. (2018). Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Blood Advances. https://doi.org/10.1182/bloodadvances.2017010694
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.